Current Problems In Cancer

SCI SCIE

国际简称：CURR PROB CANCER 参考译名：当前的癌症问题

主要研究方向：医学-肿瘤学非预警期刊审稿周期：>12周，或约稿

《当前的癌症问题》(Current Problems In Cancer)是一本由Mosby Inc.出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q3 JCR分区
34 年发文量
2.4 IF影响因子
未开放 是否OA
29 H-index
1976 创刊年份
Bimonthly 出版周期
English 出版语言

Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Papers that focus solely on laboratory-based or basic science research are discouraged. The journal's format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.

[ 查看全部 ]

投稿咨询加急咨询

Current Problems In Cancer期刊信息

ISSN：0147-0272
出版语言：English
是否OA：未开放
E-ISSN：1535-6345
出版地区：UNITED STATES
是否预警：否
出版商：Mosby Inc.
出版周期：Bimonthly
创刊时间：1976
开源占比：0.125
Gold OA文章占比：21.48%
OA被引用占比：0.0114...
出版国人文章占比：0.2
出版撤稿占比：0
研究类文章占比：88.24%

Current Problems In Cancer CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.7

0.808

0.721

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q2	178 / 428	58%
大类：Medicine 小类：Cancer Research	Q3	142 / 233	39%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Current Problems In Cancer中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ONCOLOGY 肿瘤学	4区

Current Problems In Cancer JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	214 / 333	35.9
学科：ONCOLOGY	SCIE	Q3	202 / 333	39.49

Current Problems In Cancer历年数据统计

影响因子

中科院分区

Current Problems In Cancer中国学者发文选摘

1、Efficacy and safety of immunotherapy combined with chemotherapy in both neoadjuvant and adjuvant settings among triple-negative breast cancer: A meta-analysis of randomized clinical trial
Author: Han, Jingru; Gao, Simeng; Li, Man; Li, Xiao

Journal: CURRENT PROBLEMS IN CANCER. 2026; Vol. 61, Issue , pp. -. DOI: 10.1016/j.currproblcancer.2025.101265
2、Updated perspectives on visceral pleural invasion in non-small cell lung cancer: A propensity score-matched analysis of the SEER databas
Author: Liu, Jingxin; Wang, Yibing; Zhou, Xianwei; Reng, Meijin; Xiang, Ziyue; Chang, Ruimin; Hao, Wen; Sun, Xitai; Yang, Yang

Journal: CURRENT PROBLEMS IN CANCER. 2025; Vol. 56, Issue , pp. -. DOI: 10.1016/j.currproblcancer.2025.101205
3、Efficacy and Safety of triplet versus doublet regimens in patients with multiple myeloma: A systematic review and meta-analysi
Author: Meng, Zilu; Zheng, Hanxue; Li, Yanhong; Bai, Jun; Zhang, Liansheng; Li, Lijuan

Journal: CURRENT PROBLEMS IN CANCER. 2025; Vol. 56, Issue , pp. -. DOI: 10.1016/j.currproblcancer.2025.101202
4、Beyond CTS5 score: A novel nomogram predicting long-term prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cance
Author: Zhang, Mingqi; Yu, Jing; Qin, Liang; Wu, Jiayi

Journal: CURRENT PROBLEMS IN CANCER. 2025; Vol. 56, Issue , pp. -. DOI: 10.1016/j.currproblcancer.2025.101201
5、Mapping the expression and functional landscape of key enzymes in glucose metabolism within human gynecological tumor
Author: Zhang, Wen; Lin, Ying-Tong; Jiang, Jing-Wen; Hu, Yan

Journal: CURRENT PROBLEMS IN CANCER. 2025; Vol. 54, Issue , pp. -. DOI: 10.1016/j.currproblcancer.2024.101155